INHA and tuberculosis: Mycolic acid biosynthesis is essential in mycobacteria and not conserved in non-actinobacteria or eukaryotes, making this process a very attractive target for the development of specific antimycobacterials to treat TB and increasing the value of understanding how C10 sensitizes Mtb to inhibition of InhA.